Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction

For decades, the Indian pharmaceutical industry has measured success using familiar, volume-driven metrics: prescriptions generated, market share gained, sales force productivity, doctor coverage, and quarterly revenue growth.

Yet, one critical stakeholder has remained largely absent from this commercial equation—the patient.

This omission is rapidly becoming a significant strategic vulnerability. As India's disease burden shifts decisively toward chronic illnesses, the industry is discovering that its future depends not merely on selling more molecules, but on helping patients remain healthier, adhere to their treatments, and achieve better clinical outcomes.